Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anne M. Saarikko"'
Autor:
Veera V. Pitkänen, MD, Suvi A. Alaluusua, MA, Ahmed Geneid, MD, PhD, Pia M. B. Vuola, MD, Junnu Leikola, MD, PhD, Anne M. Saarikko, MD, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 10, Iss 11, p e4678 (2022)
Background:. Velopharyngeal dimensions change as a child with cleft palate (CP) grows. The aim of this study was to assess if the decision for velopharyngeal insufficiency (VPI) surgery can be made by the age of 3 years among CP children with moderat
Externí odkaz:
https://doaj.org/article/43125a8c1ca24164ba009413d155543f
Autor:
Eeva H. Rannikko, MD, Sinikka H. Suominen, MD, PhD, Anne M. Saarikko, MD, PhD, Tiina P. Viitanen, MD, PhD, Maija T. Mäki, MD, PhD, Marko P. Seppänen, MD, PhD, Erkki A. Suominen, MD, PhD, Pauliina Hartiala, MD, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 9, Iss 1, p e3354 (2021)
Background:. Our objective was to analyze whether a correlation could be observed between preoperative factors and microvascular lymph node transfer outcome after long-term follow-up. Methods:. We included 67 patients in this retrospective case serie
Externí odkaz:
https://doaj.org/article/74ea9d508d094225a1914b6afc0de286
Autor:
Erika Hoppela, MD, Tove J. Grönroos, PhD, Anne M. Saarikko, MD, PhD, Tomi V. Tervala, MD, Susanna Kauhanen, MD, PhD, Pirjo Nuutila, MD, PhD, Katri Kivinen, MD, PhD, Pauliina Hartiala, MD, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 6, p e1804 (2018)
Background:. Fat grafting is commonly used when treating soft-tissue defects. However, much of the basic biology behind fat transfer is still uncovered. Adipocytes can be divided into energy storing white and energy burning brown adipose cells. It is
Externí odkaz:
https://doaj.org/article/2ffc4c0c39ed4231805953ff415c4f40
Autor:
Ida-Maria Leppäpuska, Pauliina Hartiala, Sinikka Suominen, Erkki Suominen, Ilkka Kaartinen, Maija Mäki, Marko Seppänen, Juha Kiiski, Tiina Viitanen, Outi Lahdenperä, Antti Vuolanto, Kari Alitalo, Anne M. Saarikko
BACKGROUND: Lymphedema is a common problem after breast cancer treatment. Lymfactin (R) is a prolymphangiogenic growth factor vector inducing the expression of human vascular endothelial growth factor C (VEGF-C). It promotes growth and repair of lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::359cfc4bae98b8c6d7ee03e503269cf4
https://trepo.tuni.fi/handle/10024/145148
https://trepo.tuni.fi/handle/10024/145148
Autor:
Pauliina, Hartiala, Sinikka, Suominen, Erkki, Suominen, Ilkka, Kaartinen, Juha, Kiiski, Tiina, Viitanen, Kari, Alitalo, Anne M, Saarikko
Publikováno v:
Journal of plastic, reconstructiveaesthetic surgery : JPRAS. 73(9)
To study the safety and tolerability of LymfactinUpper limb lymphedema is a common clinical challenge after breast cancer surgery and/or radiotherapy. LymfactinIn Phase I, LymfactinFifteen patients with breast cancer-associated secondary lymphedema o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::935bbc5aac8ed4de42c5ff472b422b2c
https://pubmed.ncbi.nlm.nih.gov/32513642
https://pubmed.ncbi.nlm.nih.gov/32513642